Biotech
Vienna: • Solubilization of the immunomodulator tacrolimus up to 200 times greater using Marinosolv®
• Bioavailability in the eye up to 15 times higher under laboratory conditions when compared to comme ...
Bremen: A paradigm shift in the cultivation of spheroids, organoids and tissue specimen in stem cell research ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/20/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of ca ...
CHICAGO, IL: CHICAGO, IL -- (Marketwired) -- 11/16/17 -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million sec ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/16/17 -- Angle PLC (OTCQX: ANPCY) (AIM: AGL)ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, further to the announcemen ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/15/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of c ...
EDMONTON, ALBERTA: - Recent entry into the cosmeceuticals sector with launch of proprietary line of products - Company continues advancement for expansion into the nutraceutical market - Completion of bio-efficacy study ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 11/13/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that it was notified today by its partner, TaiMed Biologics, Inc. ("TaiMed") ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/13/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of ca ...
TORONTO, ONTARIO: - Patient enrollment for both Phase 1 trials of TTI-621 exceeding expectations - TTI-621 Phase 1 trials on track for end of year clinical updates - Cash and marketable securities of $64.3 million at S ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/06/17 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its third quarter 2017 financial results.F ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 11/06/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building of businesses in the life sciences space, to ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/06/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL) a clinical stage immuno-oncology company developing innovative therapies for the treatment of ca ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/06/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)(AIM:AGL OTCQX:ANPCY)Contacts:
RNS
Customer
Services
0044-207797-4400 ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/06/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)(AIM:AGL OTCQX:ANPCY)Contacts:
RNS
Customer
Services
0044-207797-4400 ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/06/17 -- Angle PLC (OTCQX: ANPCY) (AIM: AGL)(AIM:AGL OTCQX:ANPCY)Contacts:
RNS
Customer
Services
0044-207797-4400 ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/02/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)Contacts:
RNS
Customer
Services
0044-207797-4400 ...
GUILDFORD, ENGLAND: GUILDFORD, ENGLAND -- (Marketwired) -- 11/01/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that further to th ...
GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 10/31/17 -- ANGLE plc (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYANGLE plc (AIM: AGL) (OTCQX: ANPCY), a world-leading liquid biopsy company, announces that at t ...
COLUMBUS, OH: Biotechnology company will globally develop and commercialize drug for treatment of advanced metastatic breast cancer ...
